Digital Health and Informatics | May Round-Up 2025

June 4, 2025
Newsletter Update
Clinical Diagnostics

Highlights & Summary  

May 2025 brought new partnerships, funding, and exciting research in the digital health world!

Read more here:

Disease Management / Digital Therapeutics

Duke, Google, and OURA partnered to develop digital solutions for opioid use disorders, Alphabet’s Verily received a grant from The Michael J. Fox Foundation to build a groundbreaking Parkinson’s molecular dataset, and Viz.ai collaborated with Sanofi and Regeneron to further test its AI-powered COPD management tool.

Informatics / Healthcare IT Solutions

Datavant acquired Aetion to enhance real-world evidence generation, Plenful raised $50M to expand its AI-powered healthcare automation platform, and Microsoft added Grok 3 to Azure to support AI applications in healthcare and life sciences.

Women’s Health / Femtech

The Global Ovarian Cancer Research Consortium and Microsoft launched a $1M AI grant to advance ovarian cancer care, Visolyr partnered with HITLAB to develop an AI platform for women’s health, and Hinge Health raised $437M in its IPO, spotlighting investor confidence in digital women’s health solutions.

Disease Management / Digital Therapeutics 

1 | Duke University, Google Fitbit, ŌURA, and more partner to develop solutions against the opioid epidemic

2 | Alphabet’s Verily receives grant from The Michael J. Fox Foundation to build Parkinson’s molecular dataset

3 | Viz.ai announces collaboration with Sanofi and Regeneron to improve management and care of COPD

Informatics / Healthcare IT Solutions  

1 | Datavant acquires Aetion to expand RWE platform

2 | Plenful scores $50M to further improve healthcare operations 

3 | Microsoft adds Grok 3 to Azure, citing healthcare and science use cases

Women’s Health / Femtech 

1 | Global Ovarian Cancer Research Consortium partners with Microsoft to launch a $1M grant to improve survival rates

2 | Visolyr and HITLAB partner to advance AI solutions for women’s health

3 | Hinge Health announces launch of initial public offering

 

Disease Management / Digital Therapeutics 

1 | Duke University, Google Fitbit, ŌURA, and more partner to develop solutions against the opioid epidemic

The Digital Medicine Society has launched a groundbreaking collaboration with Duke University, Google Fitbit, ŌURA, UNC Chapel Hill, and others to develop a tool aimed at preventing relapse and reducing deaths from opioid use disorder, which affects 5.7 million Americans and causes approximately 81,000 deaths annually. This initiative leverages AI and real-time sensor data from consumer wearables and smartphones to detect physiological and behavioral signals associated with relapse, including heart rate variability, insomnia, and social isolation. Co-led by Duke’s BIG IDEAs Lab, the project will enter a five-month research phase, including patient recruitment and a pilot study, to train predictive models for relapse prevention. By integrating digital health, AI, and cross-sector expertise, the effort aims to deliver scalable, life-saving tools for opioid use disorder recovery and public health impact.

2 | Alphabet’s Verily receives grant from The Michael J. Fox Foundation to build Parkinson’s molecular dataset

Verily, Alphabet’s health data and AI company, announced a $14.7 million grant from The Michael J. Fox Foundation to create a more comprehensive molecular dataset for Parkinson’s disease research. Building on the Personalized Parkinson’s Project, a two-year longitudinal study of 520 individuals, Verily will integrate advanced molecular profiling of biospecimens with existing clinical, imaging, and wearable data. Using its platform, Verily will make this unified dataset publicly accessible to researchers worldwide. The initiative aims to uncover genetic, immunological, and metabolic insights into Parkinson’s, accelerate diagnostic and therapeutic breakthroughs, and improve outcomes for the nearly 1 million Americans living with the disease.

3 | Viz.ai announces collaboration with Sanofi and Regeneron to improve management and care of COPD

Viz.ai announced a multi-year partnership with Sanofi and Regeneron to launch and evaluate an AI-powered workflow solution for chronic obstructive pulmonary disease, a progressive respiratory illness affecting nearly 392 million people globally. Supported by both pharmaceutical leaders, the Viz module will use electronic health record data and AI, including natural language processing, to identify high-risk patients and streamline care coordination. Integrated into Viz.ai’s platform, which is already deployed across 1,700 hospitals, the tool aims to improve early detection, follow-up, and treatment outcomes in a disease that remains underdiagnosed and undertreated worldwide.

Informatics / Healthcare IT Solutions 

1 | Datavant acquires Aetion to expand RWE platform

Datavant is acquiring Aetion to create a comprehensive digital health platform that enables healthcare and life sciences organizations to generate scalable, real-world evidence from connected, privacy-protected data. The integration combines Datavant’s secure data exchange network with Aetion’s analytics and evidence-generation tools, enhancing data discovery, curation, and analysis across the clinical and commercial lifecycle. This partnership aims to streamline the generation of regulatory-grade insights and improve data-driven decision-making in treatment development and patient care.

2 | Plenful scores $50M to further improve healthcare operations 

Plenful has raised a $50 million Series B to accelerate efforts to implement AI-driven automation to reduce administrative burdens in healthcare operations. Its digital health platform streamlines high-volume, manual workflows, such as prior authorizations and 340B audits, helping healthcare teams improve efficiency, accuracy, and staff well-being. With over 60 customers and growing traction, the company plans to invest in product innovation, customer support, and team expansion to further transform healthcare operations.

3 | Microsoft adds Grok 3 to Azure, citing healthcare and science use cases

Microsoft is integrating xAI’s Grok 3 and Grok 3 Mini into its Azure AI Foundry, expanding access to large language models with strengths in mathematics, coding, scientific reasoning, and medical diagnosis support. The move positions Grok as a tool for healthcare and life sciences organizations seeking AI-driven insights and research acceleration. Grok 3, trained on xAI’s Colossus supercluster, offers enterprise-ready customization through Azure’s scalable infrastructure and is now available in preview.

Women’s Health / Femtech 

1 | Global Ovarian Cancer Research Consortium partners with Microsoft to launch a $1M grant to improve survival rates

On World Ovarian Cancer Day, the newly formed Global Ovarian Cancer Research Consortium (which spans the U.S., U.K., Canada, and Australia) launched a $1 million AI Accelerator Grant, with an additional $1 million in cloud computing credits from Microsoft’s AI for Good Lab, to drive innovation in ovarian cancer research. The initiative aims to harness digital health tools and AI to improve early detection, treatment, and survival outcomes for ovarian cancer, which continues to see stagnant survival rates and rising global incidence. Teams applying for the grant must include representation from each participating country and will use Microsoft Azure’s cloud computing capabilities with the goal of accelerating research breakthroughs.

2 | Visolyr and HITLAB partner to advance AI solutions for women’s health

Visolyr has partnered with HITLAB to advance a Generative AI platform focused on transforming women’s health through digital innovation. The platform aims to improve clinical workflows, patient engagement, and care delivery for high-burden conditions affecting women, including cardiometabolic disease, kidney disease, and hypertension. By combining intelligent automation and real-time AI insights with HITLAB’s research and ecosystem expertise, the collaboration supports more personalized, accessible, and efficient digital health solutions for women.

3 | Hinge Health announces launch of initial public offering

Hinge Health, a digital musculoskeletal care company, raised ~$437 million in its IPO and began trading on the NYSE under the symbol HNGE. The company offers a range of digital health solutions, including its dedicated women’s pelvic health program. Hinge Health has formed strategic partnerships to expand its reach, including a collaboration with women’s virtual care provider Midi Health, furthering its involvement in advancing women's health through digital platforms. This IPO is an indicator of continued traction in women’s health applications of digital health.

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch